Gilead deepens its stake in Assembly Biosciences; NGM licenses out MASH drug

Plus, news about Abilita Therapeutics, Orion, Novartis, XGEN Venture, Palleon, Henlius, TigaTx, HERVolution Therapeutics and Krystal Biotech: Gilead now owns 30% of Assembly Biosciences: The drugmaker made a $20.1 million equity ...